Results
8
8 companies
WuXi XDC Cayman
Market Cap: HK$69.4b
An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.
2268
HK$57.65
7D
-6.9%
1Y
213.0%
Everest Medicines
Market Cap: HK$24.6b
A biopharmaceutical company, engages in the discovery, license-in, development, and commercialization of therapies and vaccines to address critical unmet medical needs in Greater China and other Asia Pacific markets.
1952
HK$70.15
7D
0.3%
1Y
279.2%
CanSino Biologics
Market Cap: HK$16.6b
Develops, manufactures, and commercializes vaccines in the People’s Republic of China.
6185
HK$47.42
7D
-3.5%
1Y
166.1%
Cutia Therapeutics
Market Cap: HK$2.9b
An investment holding company, engages in the research, development, manufacture, and commercialization of scalp diseases and care products, and skin care products in the People’s Republic of China and Hong Kong.
2487
HK$9.24
7D
7.6%
1Y
-2.1%
JBM (Healthcare)
Market Cap: HK$2.5b
An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally.
2161
HK$3.07
7D
7.0%
1Y
248.9%
Innovent Biologics
Market Cap: HK$162.1b
A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, and internationally.
1801
HK$94.65
7D
-0.4%
1Y
117.8%
Essex Bio-Technology
Market Cap: HK$3.2b
An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.
1061
HK$5.72
7D
5.3%
1Y
131.6%
Frontage Holdings
Market Cap: HK$3.0b
A contract research organization, provides laboratory and related services to pharmaceutical, biotechnology, and agrochemical companies.
1521
HK$1.50
7D
-3.8%
1Y
123.9%